tourmaline-al1: ixazomib-dexamethasone for al amyloidosis
Published 4 years ago • 83 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
1:57
tourmaline-al1: ixazomib and dexamethasone for al amyloidosis
-
3:36
tourmaline-al1: ixazomib for al amyloidosis
-
1:26
evaluating the efficacy of ixazomib, cyclophosphamide and dexamethasone in amyloidosis
-
0:52
tocilizumab for aa amyloidosis
-
1:40
long-term follow-up of the tourmaline-mm1 trial
-
13:33
unboxing bi-colored gems with jay
-
11:35
ixazomib-lenalidomide-dexamethasone in routine clinical practice
-
4:26
never take bile salts with these 3 conditions
-
2:54
tourmaline-mm4: oral ixazomib maintenance for myeloma
-
2:20
new prognostic markers in al amyloidosis
-
1:33
post-hoc analysis of tourmaline-mm1 data while adjusting for subsequent therapies
-
5:16
the evolution of al amyloidosis therapy
-
2:36
what does the tourmaline-mm2 study tell us about the use of ixazomib in multiple myeloma?
-
4:47
tourmaline-mm4: oral ixazomib maintenance for myeloma
-
4:48
overview of the final analysis of the phase iii tourmaline-mm1 trial
-
1:35
vital results for birtamimab in al amyloidosis
-
1:55
quantifying biomarkers on lambda amyloidogenic light chains to diagnose al amyloidosis
-
1:59
safety of birtamimab in al amyloidosis: pooled analysis from multiple studies
-
2:21
tourmaline-mm1 study produces optimistic results for mm
-
1:22
long-term follow-up results of tourmaline-mm2: ird vs pbo-rd in multiple myeloma
-
2:52
assessing the value of various prognostic biomarkers in al amyloidosis
-
0:52
monitoring, diagnosing & managing cardiotoxicity in al amyloidosis